The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug
Sverre E. Kjeldsen,
Krzysztof Narkiewicz,
Michel Burnier,
Suzanne Oparil
Affiliations
Sverre E. Kjeldsen
Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital
Krzysztof Narkiewicz
Department of Hypertension and Diabetology, Medical University of Gdansk
Michel Burnier
Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois
Suzanne Oparil
Vascular Biology and Hypertension Program, Department of Medicine, University of Alabama at Birmingham